2 completed, 1 active not recruiting, 1 not yet recruiting, 1 withdrawn. 5 Phase 2, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1 |
| Phase 3 | 3 | Active not recruiting 1, Not yet recruiting 1, Withdrawn 1 |
Follow Minervax ApS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pivotal Safety and Immunogenicity GBS-NN/NN2 Vaccine Maternal Immunisation Trial GBS-NN/NN2 vaccine, Placebo - Streptococcus Agalactiae Infection, Neonatal Sepsis | Phase 2 / Phase 3 | Not yet recruiting | Minervax ApS | 6600 | 2026-11-30 | 2026-11-06 |
| A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women GBS-NN/NN2 vaccine - Streptococcus Agalactiae Infection, Neonatal Sepsis | Phase 2 / Phase 3 | Active not recruiting | Minervax ApS | 137 | 2025-03-07 | 2026-09-04 |
| GBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydrogel®) Given With and Without the Tdap Vaccine in Healthy Non-pregnant Women 18 to 49 Years of Age GBS-NN/NN2 vaccine, Tdap vaccine, Placebo - Streptococcus Agalactiae Infection | Phase 2 / Phase 3 | Withdrawn | Minervax ApS | 2024-12-17 | 2026-10-13 | |
| Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women GBS-NN/NN2 Vaccine, Placebo - Group B Streptococcal Infection | Phase 2 | Completed | Minervax ApS | 269 | 2022-02-17 | 2025-06-11 |
| Study of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Have HIV GBS-NN/NN2, Placebo - Group B Streptococcal Infection | Phase 2 | Completed | Minervax ApS | 200 | 2020-11-19 | 2026-07-14 |
Streptococcal Infections (5) · Meningitis (2) · Neonatal Sepsis (2) · Pneumonia (2) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Gram-Positive Bacterial Infections (1) · Infections (1)
Boostrix (1) · Saline Solution (1)
South Africa (3) · Denmark (2) · Uganda (1) · United Kingdom (1)
Cornelia Oostvogels (2) · Jeannett Dimsits (1)
2023 (1)